ECMO is a selectively available therapeutic option, generally at a large-size referral healthcare system. In a single-center experience of use of veno-venous ECMO for COVID-19 ARDS in a medium-size healthcare system during the pandemic, West and colleagues in their study have convincingly demonstrated that ECMO can become a broadly available therapeutic option without compromising quality.